Literature DB >> 14624029

Cyclin-dependent kinases in neural development and degeneration.

Anthony C B Lim1, Robert Z Qi.   

Abstract

There is increasing evidence suggesting that cyclin-dependent kinases (Cdks) that normally regulate cell cycle progression may also be involved in the pathogenesis of neurodegenerative disorders and in the apoptotic death of neurons subjected to various insults. Deregulation of Cdks has been observed in an increasing number of neurological disorders, including Alzheimer's and Parkinson's diseases as well as amyotrophic lateral sclerosis (ALS). Unchecked expression of these proteins can potently induce apoptotic or necrotic neuronal cell death. Cdks initiate death pathways by derepressing E2F-1/pRb-dependent transcription at neuronal G1/S checkpoint. On the contrary, deregulation of Cdk5, which is not involved in cell cycle control, contributes to neurodegeneration by altering the phosphorylation state of non-membrane-associated proteins. This review describes work indicating Cdks' roles in the nervous system and how they may cogitate in leading neurons to their demise.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14624029     DOI: 10.3233/jad-2003-5409

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  16 in total

Review 1.  Role of cell cycle re-entry in neurons: a common apoptotic mechanism of neuronal cell death.

Authors:  Jaume Folch; Felix Junyent; Ester Verdaguer; Carme Auladell; Javier G Pizarro; Carlos Beas-Zarate; Mercè Pallàs; Antoni Camins
Journal:  Neurotox Res       Date:  2011-10-01       Impact factor: 3.911

2.  Activation of ataxia telangiectasia muted under experimental models and human Parkinson's disease.

Authors:  Antoni Camins; Javier G Pizarro; Daniel Alvira; Javier Gutierrez-Cuesta; Aurelio Vazquez de la Torre; Jaume Folch; Francesc X Sureda; Ester Verdaguer; Felix Junyent; Joaquín Jordán; Isidre Ferrer; Mercè Pallàs
Journal:  Cell Mol Life Sci       Date:  2010-05-26       Impact factor: 9.261

Review 3.  Cell cycle molecules define a pathway required for neuron death in development and disease.

Authors:  Lloyd A Greene; David X Liu; Carol M Troy; Subhas C Biswas
Journal:  Biochim Biophys Acta       Date:  2006-12-13

4.  Inhibition of multiple pathways accounts for the antiapoptotic effects of flavopiridol on potassium withdrawal-induced apoptosis in neurons.

Authors:  Ester Verdaguer; Elvira G Jordà; Daniel Alvira; Andrés Jiménez; Anna Maria Canudas; Jaume Folch; Victor Rimbau; Mercè Pallàs; Antoni Camins
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 5.  Insights into the regulation of neuronal viability by nucleophosmin/B23.

Authors:  Jason A Pfister; Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-22

6.  Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS-PAGE.

Authors:  Tomohisa Hosokawa; Taro Saito; Akiko Asada; Kohji Fukunaga; Shin-Ichi Hisanaga
Journal:  Mol Cell Proteomics       Date:  2010-01-23       Impact factor: 5.911

Review 7.  Class IIA HDACs in the regulation of neurodegeneration.

Authors:  Nazanin Majdzadeh; Brad E Morrison; Santosh R D'Mello
Journal:  Front Biosci       Date:  2008-01-01

8.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

9.  A three-dimensional dementia model reveals spontaneous cell cycle re-entry and a senescence-associated secretory phenotype.

Authors:  Veronica Porterfield; Shahzad S Khan; Erin P Foff; Mehmet Murat Koseoglu; Isabella K Blanco; Sruthi Jayaraman; Eric Lien; Michael J McConnell; George S Bloom; John S Lazo; Elizabeth R Sharlow
Journal:  Neurobiol Aging       Date:  2020-02-19       Impact factor: 4.673

10.  Distinct regulation of cell cycle and survival in lymphocytes from patients with Alzheimer's disease and amyotrophic lateral sclerosis.

Authors:  Fernando Bartolomé; Ursula Muñoz; Noemí Esteras; Jesús Esteban; Félix Bermejo-Pareja; Angeles Martín-Requero
Journal:  Int J Clin Exp Pathol       Date:  2008-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.